Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

20.920
+0.4402.15%
Volume:1.24M
Turnover:25.92M
Market Cap:21.48B
PE:-24.05
High:21.400
Open:20.860
Low:20.680
Close:20.480
52wk High:38.640
52wk Low:12.000
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:0.75
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-16.84%
ROA:-4.93%
PB:3.14
PE(LYR):-24.05
PS:7.57

Loading ...

Is It Time To Reassess Shanghai Junshi Biosciences (SEHK:1877) After Its Recent Share Price Strength

Simply Wall St.
·
Mar 22

Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026

Bulletin Express
·
Mar 20

Stock Track | Junshi Biosciences Soars 5.04% Intraday as Chairman Increases Stake

Stock Track
·
Mar 17

Junshi Biosciences' Chairman Raises Stake for 12 Million Yuan

MT Newswires Live
·
Mar 17

BRIEF-Shanghai Junshi Biosciences Says As At Mar 16, Controlling Shareholder Increased A Shares By 365,382 Shares For Total RMB12.2 Mln

Reuters
·
Mar 16

JUNSHI BIO Chairman Xiong Jun Increases Holdings by 365,400 A-Shares

Stock News
·
Mar 16

JUNSHI BIO Reports 28.23% Revenue Increase to RMB 2.5 Billion for 2025

Deep News
·
Mar 16

Shanghai Junshi Biosciences SEHK 1877 Valuation After Mixed Recent Share Performance And DCF Upside Potential

Simply Wall St.
·
Mar 15

Press Release: Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates

Dow Jones
·
Mar 13

Junshi Bio (01877) posts RMB0.88 billion 2025 loss, skips dividend, sets RMB5.00 billion guarantee cap and taps up to RMB1.50 billion idle proceeds for liquidity

Bulletin Express
·
Mar 13

JUNSHI BIO Revamps Board Committee to Include ESG Oversight

Stock News
·
Mar 13

Junshi Bio (01877) Announces Updated Board Composition and Committee Structure

Bulletin Express
·
Mar 13

Junshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies

Bulletin Express
·
Mar 13

BRIEF-Shanghai Junshi Biosciences Says Resolution On Temporary Replenishment Of Liquidity Approved

Reuters
·
Mar 13

Junshi Bio (01877) Fully Returns RMB1.11 Billion of Idle Proceeds Previously Deployed for Working-Capital Needs

Bulletin Express
·
Mar 12

Shanghai Junshi Biosciences - Proceeds Would Only Be Used for Business Expansion, Others

THOMSON REUTERS
·
Mar 12

Shanghai Junshi Biosciences - Resolution on Temporary Replenishment of Liquidity Approved to Use Idle Proceeds of No More Than RMB2 Bln (Inclusive)

THOMSON REUTERS
·
Mar 12

Junshi Biosciences Excluded from STAR 50 Index as Revenue Growth Fails to Reverse Loss Trend

Deep News
·
Mar 12

BRIEF-Shanghai Junshi Biosciences Says Chairman Intended To Increase Shareholding In Co

Reuters
·
Mar 11

JUNSHI BIO Chairman Xiong Jun Increases Holdings with 100,000 A Shares

Stock News
·
Mar 10